(Q35597763)

9 August 2017

1 reference

title

Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy (English)

1 reference

9 August 2017

0 references

0 references

D S Rampton

1

1 reference

9 August 2017

language of work or name

English

0 references

publication date

19 August 2005

1 reference

9 August 2017

1 reference

9 August 2017

volume

54

1 reference

9 August 2017

issue

10

1 reference

9 August 2017

page(s)

1360-1362

1 reference

Biological therapies in the spondyloarthritides--the current state

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Infliximab treatment of rheumatoid arthritis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Optimizing anti-TNF treatment in inflammatory bowel disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Infliximab in the treatment of Crohn's disease: a user's guide for clinicians

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Granulomatous infectious diseases associated with tumor necrosis factor antagonists

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774683

26 September 2018

Identifiers

DOI

10.1136/GUT.2005.076034

1 reference

9 August 2017

1 reference

9 August 2017

1 reference